Ellis Andrea

Director at BBIO

Sold, on record
$7.9M
Dollars the filings state
Form 4 sales
5
Latest Jul 9, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • BBIOBridgeBio Pharma, Inc.Director

Sales by reason

1
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale BBIORoutine
    Apr 1 2025

    Sold 30,000 shares at $34.05 ($1M)

    Ellis Andrea, Director

    10b5-1 planSold 71.4% of holdings ($1.4M position)12,000 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale BBIORoutine
    Apr 14 +13 days

    Sold 10,000 shares at $35.00 ($350k)

    Ellis Andrea, Director

    10b5-1 planSold 45.5% of holdings ($770k position)12,000 shares leftFiling

  3. 3 Form 4 sale BBIORoutine
    Aug 5 +113 days

    Sold 17,167 shares at $49.00 ($841k)

    Ellis Andrea, Director

    10b5-1 planSold 48% of holdings ($1.8M position)18,589 shares leftFiling

  4. 4 Form 4 sale BBIOUnusual
    Mar 4 +211 days

    Sold 64,921 shares at $64.87 ($4.2M)

    Ellis Andrea, Director

    10b5-1 planSold 77.7% of holdings ($5.4M position)18,589 shares left3.8x usual sizeFiling

  5. 5 Form 4 sale BBIORoutine
    Jul 9 +127 days

    Sold 17,167 shares at $84.00 ($1.4M)

    Ellis Andrea, Director

    10b5-1 planSold 43.2% of holdings ($3.3M position)22,579 shares left0.7x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (5)

Form 144 notices and Form 4 sales by Ellis Andrea
Source
Jul 9, 2026BBIODirectorForm 4 sale17,167$1.4M43.2%RoutineSEC
Mar 4, 2026BBIODirectorForm 4 sale64,921$4.2M77.7%UnusualSEC
Aug 5, 2025BBIODirectorForm 4 sale17,167$841k48.0%RoutineSEC
Apr 14, 2025BBIODirectorForm 4 sale10,000$350k45.5%RoutineSEC
Apr 1, 2025BBIODirectorForm 4 sale30,000$1M71.4%RoutineSEC